News for Healthier Living

Neuroscientist Searches for Ways to Reduce Seizures in Children

Mutations in the KCNT1 gene can cause severe, treatment-resistant epilepsy in about 3,000 U.S. children. Fralin Biomedical Research Institute scientist Matthew Weston is testing a KCNT1 inhibitor from Actio Biosciences that reduces seizures in mice. If successful, the drug could enter clinical trials by 2026, offering hope for a targeted therapy to improve outcomes.

June 18, 2025


June 18 2025

June 17 2025

June 16 2025

June 15 2025

June 14 2025

June 13 2025

June 12 2025

June 11 2025

June 10 2025

June 9 2025

June 8 2025

June 7 2025

June 6 2025

June 5 2025

June 4 2025